Sector: Health Care
Director information for ARVINAS INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Angela Cacace, Ph.D. | Chief Scientific Officer | 58 | ["Three decades of drug discovery experience in neuroscience and oncology research","Led the continuous evolution of PROTAC Discovery Engine","Vice President of Biology at Fulcrum Therapeutics, Inc.","Served in positions of increasing responsibility at BMS","Senior Principal Scientist in Cancer Biology at Pfizer","Received B.S. in Biology from Fairfield University, Ph.D. in Pharmacology from Columbia University"] | [] | 2026 |
| Briggs Morrison, M.D. | Chair of the Board | 67 | ["Extensive executive leadership experience","Medical background and training"] | [] | 2026 |
| Edward Kennedy, Jr. | Director | 64 | ["Over 25 years as a health care regulatory attorney","Extensive legal and regulatory experience","Roles as a policymaker and legislator"] | [] | 2026 |
| Everett Cunningham | Director | 59 | ["30 years of progressive responsibility in pharmaceuticals and medical services","20 years of commercial leadership across healthcare tech, life sciences and pharmaceuticals"] | [] | 2026 |
| John Houston, Ph.D. | Former President and Chief Executive Officer | 66 | ["Consultant since February 2026","Chair of the board of directors from June 2023 to February 2026","Former President of Research and Development","Former Chief Scientific Officer","Senior Vice President at Bristol-Myers Squibb","Ph.D. in microbial biochemistry from Heriot-Watt University","B.Sc. in medical microbiology from the University of Glasgow"] | [] | 2026 |
| Leslie V. Norwalk, Esq. | Director | 60 | ["Strategic counsel to Epstein Becker & Green, P.C.","Experience in healthcare and life science law","Former acting administrator of the Centers for Medicare & Medicaid Services","Experience managing federal health care programs","Former deputy administrator of the Centers for Medicare & Medicaid Services","Board member of multiple publicly-traded companies"] | [] | 2026 |
| Linda Bain | Venture Partner at Atlas Venture | 55 | ["Chief Operating Officer at Mariana Oncology","Chief Financial Officer at Codiak BioSciences","Chief Financial Officer at Avalanche Biotechnologies","Vice President of Finance at bluebird bio","Senior roles at Genzyme Corporation","Certified Public Accountant","B.Sc. in Accounting and Business Administration"] | [] | 2026 |
| Noah Berkowitz, M.D., Ph.D. | Chief Medical Officer | 62 | ["More than 20 years of experience in advancing programs through early and late stages of development","Senior Vice President Hematology Development at BMS","Held roles of increasing responsibility at Novartis, Inc.","Executive at Impath, a cancer-testing services company","Founder and Chief Executive Officer of Synvista","Trained in Medical Oncology at the National Cancer Institute","Received M.D., Ph.D. from Columbia University"] | [] | 2026 |
| Randy Teel, Ph.D. | President and Chief Executive Officer | 47 | ["20 years of biopharmaceutical industry experience","Former Chief Business Officer at Arvinas","Experience in corporate strategy, business development, and investor relations","Former Vice President and Head of Strategy at Alexion Pharmaceuticals","Experience as a consultant at McKinsey & Company","Ph.D. in Immunobiology from Yale University"] | [] | 2026 |
